Login / Signup

Does Molecular Profiling of KRAS -Mutant Non-Squamous Non-Small Cell Lung Cancer (NSCLC) Help in Treatment Strategy Planning?

Nagla Abdel KarimAsad UllahPeterson PathroseHassana FathallahAshley PerryJohn C MorrisJiang WangSandra L Starnes
Published in: Current oncology (Toronto, Ont.) (2022)
in addition to other therapeutic agents specific to the molecular profile of the tumor.
Keyphrases
  • small cell lung cancer
  • wild type
  • high grade
  • single molecule
  • single cell
  • advanced non small cell lung cancer